Literature DB >> 12749392

Fourier phase and amplitude analysis for automated objective evaluation of myocardial contrast echocardiograms.

Raffi Bekeredjian1, Thomas Hilbel, Arthur Filusch, Alexander Hansen, Andreas Benz, Joerg Zehelein, Helmut F Kuecherer.   

Abstract

AIMS: Objective methods for evaluating myocardial contrast echocardiography (MCE) are not yet widely available. We applied a Fourier analysis to myocardial contrast echocardiograms to identify myocardial perfusion defects.
METHODS: Harmonic power-Doppler contrast echocardiograms were performed in 21 patients undergoing Tl-201-SPECT imaging and in 13 controls. Images were transformed using Fourier analysis to obtain phase of the first harmonic sinusoidal curve displayed as color coded sequence of myocardial intensity changes. Means and standard deviations of regional phase angles were measured. The method was validated in an in vitro model. A contrast filled latex balloon was imaged at different gain settings mimicking defined time-intensity curves. An intraoperative porcine infarction model served to prove feasibility of Fourier transformation to analyze real-time pulse inversion contrast echocardiography.
RESULTS: In patients, phase imaging and intensity analysis showed focal areas with marked phase shifts (106 +/- 90 degrees) and heterogeneous distribution of phase angles (SD 66 +/- 17 degrees), correctly identifying 13/14 perfusion defects. The in vitro validation yielded increasing phase angles with increasing beta-values. This method was successfully applied to real-time MCE, identifying all infarction areas during occlusion of the left anterior descending artery.
CONCLUSION: Phase analysis can be used to display dynamics of myocardial opacification.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12749392     DOI: 10.1023/a:1022873803754

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  16 in total

1.  Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion.

Authors:  K Wei; A R Jayaweera; S Firoozan; A Linka; D M Skyba; S Kaul
Journal:  Circulation       Date:  1998-02-10       Impact factor: 29.690

2.  Increased ultrasound contrast and decreased microbubble destruction rates with triggered ultrasound imaging.

Authors:  T R Porter; F Xie; S Li; A D'Sa; P Rafter
Journal:  J Am Soc Echocardiogr       Date:  1996 Sep-Oct       Impact factor: 5.251

3.  Assessment of myocardial perfusion by intermittent harmonic power Doppler using SonoVue, a new ultrasound contrast agent.

Authors:  A Broillet; J Puginier; R Ventrone; M Schneider
Journal:  Invest Radiol       Date:  1998-04       Impact factor: 6.016

4.  Clinical application of power Doppler imaging to visualize coronary arteries in human beings.

Authors:  F Ishikura; R Matsuwaka; T Sakakibara; Y Sakata; A Hirayama; K Kodama
Journal:  J Am Soc Echocardiogr       Date:  1998-03       Impact factor: 5.251

5.  Kinetics of thallium exchange in cultured rat myocardial cells.

Authors:  D McCall; L J Zimmer; A M Katz
Journal:  Circ Res       Date:  1985-03       Impact factor: 17.367

6.  Echocardiographic quantification of left ventricular asynergy in coronary artery disease with Fourier phase imaging.

Authors:  A Hansen; C Krueger; S E Hardt; M Haass; H F Kuecherer
Journal:  Int J Cardiovasc Imaging       Date:  2001-04       Impact factor: 2.357

7.  Assessment of myocardial perfusion by harmonic power Doppler imaging at rest and during adenosine stress: comparison with (99m)Tc-sestamibi SPECT imaging.

Authors:  S K Heinle; J Noblin; P Goree-Best; A Mello; G Ravad; S Mull; P Mammen; P A Grayburn
Journal:  Circulation       Date:  2000-07-04       Impact factor: 29.690

8.  Detection of myocardial perfusion in multiple echocardiographic windows with one intravenous injection of microbubbles using transient response second harmonic imaging.

Authors:  T R Porter; S Li; D Kricsfeld; R W Armbruster
Journal:  J Am Coll Cardiol       Date:  1997-03-15       Impact factor: 24.094

9.  An accurate means of detecting and characterizing abnormal patterns of ventricular activation by phase image analysis.

Authors:  E H Botvinick; M A Frais; D W Shosa; J W O'Connell; J A Pacheco-Alvarez; M Scheinman; R S Hattner; F Morady; D B Faulkner
Journal:  Am J Cardiol       Date:  1982-08       Impact factor: 2.778

10.  Echocardiographic Fourier phase and amplitude imaging for quantification of ischemic regional wall asynergy: an experimental study using coronary microembolization in dogs.

Authors:  H F Kuecherer; W Schoels; L D Sterns; K Freigang; G da S Kleber; J Brachmann; W Kuebler
Journal:  J Am Coll Cardiol       Date:  1995-05       Impact factor: 24.094

View more
  4 in total

1.  Potential pitfalls of visualization of myocardial perfusion by myocardial contrast echocardiography with harmonic gray scale B-mode and power Doppler imaging.

Authors:  Hisashi Masugata; Kazushi Yukiiri; Yuichiro Takagi; Koji Ohmori; Katsufumi Mizushige; Masakazu Kohno
Journal:  Int J Cardiovasc Imaging       Date:  2004-04       Impact factor: 2.357

2.  Fourier phase analysis can be used to objectively analyze real-time myocardial contrast echocardiograms.

Authors:  Alexander Hansen; Raffi Bekeredjian; Grigorious Korosoglou; David Wolf; Arthur Filusch; Helmut F Kuecherer
Journal:  Int J Cardiovasc Imaging       Date:  2004-08       Impact factor: 2.357

3.  Quantitative detection of myocardial ischaemia by stress echocardiography; a comparison with SPECT.

Authors:  Petri Gudmundsson; Kambiz Shahgaldi; Reidar Winter; Magnus Dencker; Mariusz Kitlinski; Ola Thorsson; Ronnie B Willenheimer; Lennart Ljunggren
Journal:  Cardiovasc Ultrasound       Date:  2009-06-18       Impact factor: 2.062

4.  Head to head comparisons of two modalities of perfusion adenosine stress echocardiography with simultaneous SPECT.

Authors:  Petri Gudmundsson; Kambiz Shahgaldi; Reidar Winter; Magnus Dencker; Mariusz Kitlinski; Ola Thorsson; Lennart Ljunggren; Ronnie B Willenheimer
Journal:  Cardiovasc Ultrasound       Date:  2009-04-20       Impact factor: 2.062

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.